{"created":"2023-06-19T11:21:03.401427+00:00","id":1184,"links":{},"metadata":{"_buckets":{"deposit":"504d0d61-1b20-477d-9abc-7eac434ec7e0"},"_deposit":{"created_by":3,"id":"1184","owners":[3],"pid":{"revision_id":0,"type":"depid","value":"1184"},"status":"published"},"_oai":{"id":"oai:asahikawa-med.repo.nii.ac.jp:00001184","sets":["7","7:23"]},"author_link":["3856","3857","3858","3859","3860","3861"],"item_5_biblio_info_21":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"1997-07-01","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"2","bibliographicPageEnd":"66","bibliographicPageStart":"61","bibliographicVolumeNumber":"2","bibliographic_titles":[{"bibliographic_title":"International Journal of Clinical Oncology"}]}]},"item_5_description_33":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"本症56例中10例は不規則な非-造影剤増強領域を示した.均一増強を持つ症例の5年生存率は77.5%であるのに対し,非-造影剤増強領域を持つ症例の44ヵ月での生命保険統計的生存率は25.4%であった.11因子[病変の内部特徴(非-造影剤増強領域の有無),性,年齢,臨床病期,原発部位,病変の大きさ,乳酸脱水素酵素値,症状の有無,細胞マーカー,組織病理学的規準,及び治療法]に対するCox回帰モデルを用いる多変量解析上,症状の有無及び病変の内部特徴は予後に有意な効果を及ぼした.病変の内部特徴と他の因子との間には明らかな相関は認められなかった","subitem_description_type":"Abstract"}]},"item_5_description_36":{"attribute_name":"注記","attribute_value_mlt":[{"subitem_description":"雑誌掲載版","subitem_description_type":"Other"}]},"item_5_description_37":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"subitem_description":"text","subitem_description_type":"Other"}]},"item_5_description_41":{"attribute_name":"フォーマット","attribute_value_mlt":[{"subitem_description":"application/pdf","subitem_description_type":"Other"}]},"item_5_source_id_22":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"1341-9625","subitem_source_identifier_type":"ISSN"}]},"item_5_text_44":{"attribute_name":"ID(XooNIps)","attribute_value_mlt":[{"subitem_text_value":"1998064293"}]},"item_5_text_54":{"attribute_name":"閲覧数(XooNIps)","attribute_value_mlt":[{"subitem_text_value":"2631"}]},"item_5_text_55":{"attribute_name":"ダウンロード数(XooNIps)","attribute_value_mlt":[{"subitem_text_value":"1162"}]},"item_5_text_7":{"attribute_name":"著者 ローマ字","attribute_value_mlt":[{"subitem_text_value":"Saito, Yasuhiro"}]},"item_5_version_type_38":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"斉藤, 泰博"},{"creatorName":"サイトウ, ヤスヒロ","creatorNameLang":"ja-Kana"}],"nameIdentifiers":[{"nameIdentifier":"3856","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Mineta, Masayuki"}],"nameIdentifiers":[{"nameIdentifier":"3857","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Yamada, Tomonori"}],"nameIdentifiers":[{"nameIdentifier":"3858","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Yoshikawa, Daihei"}],"nameIdentifiers":[{"nameIdentifier":"3859","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Yoshida, Hiroshi"}],"nameIdentifiers":[{"nameIdentifier":"3860","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Aburano, Tamio"}],"nameIdentifiers":[{"nameIdentifier":"3861","nameIdentifierScheme":"WEKO"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2021-07-06"}],"displaytype":"detail","filename":"1424.pdf","filesize":[{"value":"3.0 MB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"1424.pdf","url":"https://asahikawa-med.repo.nii.ac.jp/record/1184/files/1424.pdf"},"version_id":"cef03ca2-ff45-47ea-994d-26c7c5b4c1ee"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"non-Hodgkin's Iymphoma","subitem_subject_scheme":"Other"},{"subitem_subject":"CT","subitem_subject_scheme":"Other"},{"subitem_subject":"MRI","subitem_subject_scheme":"Other"},{"subitem_subject":"necrosis","subitem_subject_scheme":"Other"},{"subitem_subject":"non-contrast-enhanced area","subitem_subject_scheme":"Other"},{"subitem_subject":"prognosis","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"Clinical Significance of Non-Hodgkin's Lymphoma with an Irregular、Non-Contrast-Enhanced Area","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Clinical Significance of Non-Hodgkin's Lymphoma with an Irregular、Non-Contrast-Enhanced Area","subitem_title_language":"en"}]},"item_type_id":"5","owner":"3","path":["6","7","23"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2009-01-26"},"publish_date":"2009-01-26","publish_status":"0","recid":"1184","relation_version_is_last":true,"title":["Clinical Significance of Non-Hodgkin's Lymphoma with an Irregular、Non-Contrast-Enhanced Area"],"weko_creator_id":"3","weko_shared_id":-1},"updated":"2024-04-19T11:32:12.283179+00:00"}